Skip to main content
. 2020 May 14;20:39. doi: 10.1186/s12873-020-00335-w

Table 3.

Outcomes stratified by tranexamic acid administration

Total (n = 71) TXA (n = 14) No TXA (n = 57) P-value
Underwent cranial decompression, n 31 (43.7%) 7 (50.0%) 24 (42.1%) 0.76
Field GCS 11.8 ± 3.8 9.2 ± 4.4 12.5 ± 3.4 0.008*
Discharge GCS 13.7 ± 3.4 13.3 ± 4.0 13.8 ± 3.2 0.58
Change in GCS 1.8 ± 3.4 3.7 ± 3.9 1.3 ± 3.1 0.02*
6-month GOS 3.7 ± 1.0 3.5 ± 0.9 3.8 ± 1.0 0.13
Mortality, n 5 (7.0%) 1 (7.1%) 4 (7.0%) 1.0